Biomerica (BMRA) Share-based Compensation Growth (5y) (2016 - 2026)
Biomerica (BMRA) Share-based Compensation Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -35.57% |
| Nov 30, 2025 | -22.25% |
| Aug 31, 2025 | -11.63% |
| May 31, 2025 | -16.90% |
| Feb 28, 2025 | -5.35% |
| Nov 30, 2024 | 39.70% |
| Aug 31, 2024 | 67.44% |
| May 31, 2024 | 112.48% |
| Feb 29, 2024 | 19.87% |
| Nov 30, 2023 | 159.24% |
| Aug 31, 2023 | 83.89% |
| May 31, 2023 | 88.38% |
| Feb 28, 2023 | 127.49% |
| Nov 30, 2022 | 320.81% |
| Aug 31, 2022 | 133.46% |
| May 31, 2022 | 91.35% |
| Feb 28, 2022 | 105.99% |
| Nov 30, 2021 | 86.81% |
| Aug 31, 2021 | 350.63% |
| May 31, 2021 | 101.25% |